4 years safety of fingolimod in real world: PANGAEA, a non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice

被引：0
|
作者：
Ziemssen, T.
Albrecht, H.
Haas, J. [1 ]
Klotz, L. [2 ]
Lang, M. [3 ]
Lassek, C.
Schmidt, S.
Tackenberg, B. [4 ]
Cornelissen, C.
机构：
[1] Jud Krankenhaus, Berlin, Germany
[2] Unilkin Munster, Klin Allgemeine Neurol, Munster, Germany
[3] NTD Study Grp, Ulm, Germany
[4] Univ Klinikum Giessen & Marburg, Marburg, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P21143
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [41] Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
    Tjalf Ziemssen
    Michael Lang
    Stephan Schmidt
    Holger Albrecht
    Luisa Klotz
    Judith Haas
    Christoph Lassek
    Stefan Lang
    Veronika E. Winkelmann
    Benjamin Ettle
    Ulf Schulze-Topphoff
    Journal of Neurology, 2022, 269 : 3276 - 3285
  • [42] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
    Izquierdo, Guillermo
    Damas, Fatima
    Dolores Paramo, Maria
    Luis Ruiz-Pena, Juan
    Navarro, Guillermo
    PLOS ONE, 2017, 12 (04):
  • [43] A prospective multicentre, non-interventional, real-world study to assess the pattern of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
    Blockeel, C.
    Griesinger, G.
    Rago, R.
    Riviere, S.
    Larsson, P.
    Sonderegger, Y. L. Yip
    Laven, J. S. E.
    HUMAN REPRODUCTION, 2022, 37
  • [44] Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
    Blockeel, Christophe
    Griesinger, Georg
    Rago, Rocco
    Larsson, Per
    Sonderegger, Yum Lina Yip
    Riviere, Stephane
    Laven, Joop S. E.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [45] REALMS study: a non-interventional retrospective, multicenter study to evaluate the effectiveness of fingolimod therapy in real-life clinical practice in patients with relapsing-remitting multiple sclerosis (RRMS) in Portugal
    Batista, S.
    Nunes, C. C.
    Mendonca, M. T.
    Sa, J.
    Correia, A. S.
    Sequeira, J.
    Salgado, V.
    Cerqueira, J.
    Pinheiro, J.
    Silva, A. M.
    Sousa, L.
    Costa, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 950 - 950
  • [46] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    Batista, S.
    Nunes, C. C.
    Cerqueira, J. J.
    Martins Silva, Ana
    Correia de Sa, J.
    Ferreira, J.
    Mendonca, M. T.
    Pinheiro, J.
    Salgado, V.
    Correia, A. S.
    Sequeira, J.
    Costa, A.
    Sousa, L.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
  • [47] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    S. Batista
    C. C. Nunes
    J. J. Cerqueira
    Ana Martins Silva
    J. Correia de Sá
    J. Ferreira
    M. T. Mendonça
    J. Pinheiro
    V. Salgado
    A. S. Correia
    J. Sequeira
    A. Costa
    L. Sousa
    Neurological Sciences, 2021, 42 : 1995 - 2003
  • [48] Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management
    Backer, Vibeke
    Ellery, Adam
    Borzova, Sylvia
    Lane, Stephen
    Kleiberova, Magda
    Bengtsson, Peter
    Tomala, Tadeusz
    Basset-Stheme, Dominique
    Bennett, Carla
    Lindner, Dirk
    Meiners, Arthur
    Overend, Tim
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [49] Tolerability and safety of Fingolimod in Spanish Clinical practice. Pooled Analysis data: Study Fingoview
    Izquierdo, Guillermo
    Meca-Lallana, Jose
    Ara, Jose Ramon
    Oreja-Guevara, Celia
    Diaz, Lucia Forero
    Mallada, Javier
    Ayuso, Teresa
    Sempere, Angel Perez
    Herrera, Nicolas
    Contreras, Yessica
    Salutregui, Izaskun
    Ricart, Javier
    Garcia, Eli
    NEUROLOGY, 2017, 88
  • [50] Safety and Effectiveness of Tocilizumab in Patients with Renal Insufficiency in the Non-interventional Study ICHIBAN
    Specker, Christof
    Aringer, Martin
    Burmester, Gerd
    Gerlach, Johannes
    Hofmann, Michael
    Kellner, Herbert
    Moosig, Frank
    Tony, Hans-Peter
    Fliedner, Gerhard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345